Category Archives: Cell Medicine

Asymmetrex Stem Cell Medicine By: Brad Cooper … Continue reading →

Miami, FL (PRWEB) November 05, 2014 Global Stem Cells Group, its subsidiary Stem Cell Training, Inc. and Dr. J. Victor Garcia have announced plans to conduct the Adipose Derived Harvesting, Isolation and Re-integration Training Course in Barcelona, Spain Nov. 22-23. 2014. The two-day, hands-on intensive training course, which will be conducted by Garcia, was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. The objective of the training is to bridge the gap between bench science in the laboratory and the doctors office by teaching effective, in-office regenerative medicine techniques. For more information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-224-1858. About Global Stem Cells Group: Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries … Continue reading →

Step 1 - lupus / diabetes / alzheimers syrum - Take 5ml blood Contact Josh@mexicoassistedliving.com for more information about this amazing stem cell medicine that is helping to treat people with lupus, anti-immune disorders, alzheimers, diabetes type... By: Joshua Ketner … Continue reading →

(PRWEB UK) 22 September 2014 BioKidz is a simple concept which aims to engage children in the importance of stem cell medicine. Aimed at an audience of 4-9 year olds, the company now aims to use it in the 21 countries in which it operates. BioEden has been invited to speak with parents and teachers later this month, as the BioKidz site aims to be a good source of scientific information for primary school teachers. The BioEden proposition is very simple one: harvest the stem cells from a naturally shed baby tooth, store the viable cells for future therapeutic use, and guarantee that the cells will be available when needed. As stem cell medicine is now becoming commonplace, it is important that there is a stem cell match when needed. The easiest way to do this is by harvesting and storing one's own cells, and there is no easier way than from naturally shed teeth. The company admits that they could be putting the ordinary tooth fairy out of business, but they hasten to add that BioKidz have their own hero in the form of a Super Tooth Fairy who works within their own stem cell laboratories. Children can meet … Continue reading →

Credit: Samantha Morris, PhD, Boston Children's Hospital As in this map on the cover of Cell, a cell has many possible destinations or fates, and can arrive at them through three main stem cell engineering methods: reprogramming (dialing a specialized cell, such as a skin cell, back to a stem-like state with full tissue-making potential) differentiation (pushing a stem cell to become a particular cell type, such as a blood cell) direct conversion (changing one kind of specialized cell to another kind) Freely available on the Internet, CellNet provides clues to which methods of cellular engineering are most effectiveand acts as a much-needed quality control tool. To date, there has been no systematic means to determine how closely cells made in a petri dish approximate natural tissues in the body, says George Q. Daley, MD, PhD, director of the Stem Cell Transplantation Program at Boston Childrens Hospital, senior investigator on two studies published by Cell last week. CellNet adds that analytical rigor and even suggests ways to make the cells better. As shown below, the algorithms inputs are engineered cells made through the different methods. The outputs are comparisons of these cells gene regulatory networks (which genes are turned on … Continue reading →

In a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a "roadmap" for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodies. CellNet and its application to stem cell engineering are described in two back-to-back papers in the August 14 issue of the journal Cell. Scientists around the world are engaged in culturing pluripotent stem cells (capable of forming all the body's tissues) and transforming them into specialized cell types for use in research and regenerative medicine. Available as an Internet resource for any scientist to use, CellNet provides a much needed "quality assurance" measure for this work. The two papers also clarify uncertainty around which methods are best for stem cell engineering, and should advance the use of cells derived from patient tissues to model disease, test potential drugs and use as treatments. For example, using CellNet, one of the studies unexpectedly found that skin cells can be converted into intestinal cells that were able to reverse colitis in … Continue reading →

Contact Information Available for logged-in reporters only Newswise Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This Phase I clinical trial is recruiting eight patients for the 5-year study. The goal of this study is to evaluate the safety of transplanting neural stem cells into the spine for what one day could be a treatment for spinal cord injuries, said Joseph Ciacci, MD, principal investigator and neurosurgeon at UC San Diego Health System. The studys immediate goal, however, is to determine whether injecting these neural stem cells into the spine of patients with spinal cord injury is safe. Related goals of the clinical trial include evaluating the stem cell grafts survival and the effectiveness of immunosuppression drugs to prevent rejection. The researchers will also look for possible therapeutic benefits such as changes in motor and sensory function, bowel and bladder function, and pain levels. Patients who are accepted for the study will have spinal cord injury to the T7-T12 level of the spines vertebrae and will have incurred their injury between one and two years ago. … Continue reading →

Contact Information Available for logged-in reporters only Newswise BIRMINGHAM, Ala. Researchers at the University of Alabama at Birmingham School of Medicine have created an experimental blood test that, for the first time, determines a Bioenergetic Health Index, or BHI, by gauging the performance of mitochondria, the cells energy powerhouses. They report their laboratory findings in a recent issue of the journal Clinical Science. Until now, a test of mitochondrial health has been elusive, experts say; but it could prove to be a significant early warning system for people with chronic diseases known to damage the mitochondria, such as HIV, alcoholic hepatitis, age-related diseases and more. Over the past few years it has become clear that mitochondrial dysfunction is central to a wide range of important human diseases, ranging from diabetes, obesity and the metabolic syndrome to inflammatory and neurodegenerative diseases, said Mike Murphy, Ph.D., group leader at the Medical Research Councils Mitochondrial Biology Unit in Cambridge, United Kingdom, who was not an author on the study. In clinical settings, patients BHI could be measured to determine their bioenergetic health baseline before they undergo different procedures, said Victor Darley-Usmar, Ph.D., a professor of pathology, director of the Mitochondrial Medicine Laboratory at … Continue reading →

PUBLIC RELEASE DATE: 28-May-2014 Contact: Robert Miranda cogcomm@aol.com Cell Transplantation Center of Excellence for Aging and Brain Repair Tampa, Fla. (May 28, 2014) To be suitable for medical transplantation, one idea is that human embryonic stem cells (hESCs) need to remain "undifferentiated" i.e. they are not changing into other cell types. In determining the best way to culture hESCs so that they remain undifferentiated and also grow, proliferate and survive, researchers have used blood cell "feeder-layer" cultures using animal-derived feeder cells, often from mice (mouse embryonic fibroblasts [MEFs]). This approach has, however, been associated with a variety of contamination problems, including pathogen and viral transmission. To avoid contamination problems, a Brazilian research team has investigated the use of human menstrual blood-derived mesenchymal cells (MBMCs) as feeder layers and found that "MBMCs can replace animal-derived feeder systems in human embryonic stem cell culture systems and support their growth in an undifferentiated stage." The study will be published in a future issue of Cell Medicine, but is currently freely available on-line as an unedited early e-pub at: http://www.ingentaconnect.com/content/cog/cm/pre-prints/content-CM1019silvadosSantos. "Human embryonic stem cells present a continuous proliferation in an undifferentiated state, resulting in an unlimited amount of cells with the potential to differentiate … Continue reading →

May 27, 2014 Image Caption: Stanford School of Medicine researchers, working with scientists at the SLAC National Accelerator Laboratory, have made discoveries about the ways in which T cell receptors (shown in bright red) recognize invaders in the body. Credit: Eric Smith & K. Christopher Garcia By Glenn Roberts Jr., Stanford University A study led by researchers at Stanfords School of Medicine reveals how T cells, the immune systems foot soldiers, respond to an enormous number of potential health threats. X-ray studies at the Department of Energys SLAC National Accelerator Laboratory, combined with Stanford biological studies and computational analysis, revealed remarkable similarities in the structure of binding sites, which allow a given T cell to recognize many different invaders that provoke an immune response. The research demonstrates a faster, more reliable way to identify large numbers of antigens, the targets of the immune response, which could speed the discovery of disease treatments. It also may lead to a better understanding of what T cells recognize when fighting cancers and why they are triggered to attack healthy cells in autoimmune diseases such as diabetes and multiple sclerosis. Until now, it often has been a real mystery which antigens T cells are … Continue reading →